摘要
目的探讨检测血清、腹水甲胎蛋白(AFP)、癌胚抗原(CEA)及糖类抗原125(CA125)与良、恶性腹水的相关性。方法放射免疫分析126例患者血清和腹水AFP,CEA及CA125的含量。结果恶性肝病腹水组血清、腹水AFP,CEA及CA125水平较之良性肝病腹水组差异非常显著(P<0.01)。结论血清和腹水中AFP,CEA及CA125水平与良、恶性腹水密切相关,联合检测对恶性肝病均有一定的诊断价值。
Objective To investigate the levels of serum and ascitic fluid AFP, CEA and CA125 for the differentiation of benign from malignant ascites. Methods Serum and ascetic fluid contents of the tumor markers AFP, CEA and CA125 were measured with RIA in 126 cases with ascites. Results The serum and ascitic fluid AFP, CEA and CA125 levels in patients with malignant ascites were significantly higher than those in patients with benign ascites（ P 〈0.01 ）. Conclusion The levels of AFP, CEA and CA125 in serum and ascetic fluid are closely related to the differentiation of benign from malignant ascites. Combined test for AFP, CEA and CA125 shows diagnostic value for malignant hepatic diseases.
出处
《临床和实验医学杂志》
2007年第6期46-47,共2页
Journal of Clinical and Experimental Medicine
